Head-to-head · Cost-Efficiency Index
Believe Health vs Thryve
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Believe Health
Readers who want the peptide catalog and are prepared to complete an intake before learning what a GLP-1 costs.
Visit Believe HealthThryve
Not currently recommendable — include only for completeness while the underlying site remains this undocumented.
Visit ThryveThe verdict
Believe Health takes it, leading the Cost-Efficiency Index 37 to 22. Believe Health sells compounded semaglutide, tirzepatide and a low-dose GLP-1, prints "AVAILABLE BY CONSULTATION" where each price belongs, and publishes 19 peptide prices on the same site. Thryve still earns a C — Not currently recommendable — include only for completeness while the underlying site remains this undocumented.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Believe Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Believe Health | Thryve |
|---|---|---|
| Cost-Efficiency Index | 37/100 | 22/100 |
| Semaglutide / mo | Not disclosed | $99/mo (drug not specified — site never names semaglutide or tirzepatide) |
| Tirzepatide / mo | Not disclosed | $99/mo (drug not specified — site never names semaglutide or tirzepatide) |
| Semaglutide / yr (modeled) | — | $1,188 |
| Tirzepatide / yr (modeled) | — | $1,188 |
| Coverage | Coverage not published | Not disclosed |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #538 | #539 |
Believe Health
37/100Where the value is
- Publishes a full peptide catalog with 19 priced entries before any intake, while publishing no GLP-1 price at all
- Names its operating company, Believe Health LLC, in terms updated in June 2026 — the August record found no entity at all
- States plainly that you are charged only after a physician approves a plan
The tradeoffs
- No GLP-1 price is published anywhere — every treatment page reads "AVAILABLE BY CONSULTATION" where a figure would sit, while the same pages promise "flat-rate pricing and no hidden fees"
- The low-dose GLP-1 is sold without naming its molecule on any page
Thryve
22/100Where the value is
- A low headline price is advertised, if a reader wants to investigate directly
The tradeoffs
- Never names which drug is being sold — no mention of semaglutide, tirzepatide, or any other active ingredient anywhere on the site
- No dose, no state-coverage list, no named clinician, and no named pharmacy found anywhere
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.